FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007298458> ?p ?o ?g. }

• W2007298458 endingPage "161" @default.
• W2007298458 startingPage "151" @default.
• W2007298458 abstract "The mitogen-activated protein kinase (MAPK) family consists of the p42/p44 MAPKs and the stress-activated protein kinases, c-Jun N-terminal kinase (JNK) and p38 MAPK. We have previously reported that the human adenosine A(1) receptor stimulates p42/p44 MAPK in transfected Chinese hamster ovary cells. In this study, we have investigated whether the endogenous adenosine A(1) receptor in the smooth muscle cell line, DDT(1)MF-2 activates p42/p44 MAPK, JNK and p38 MAPK. The adenosine A(1) receptor agonist N(6)-cyclopentyladenosine stimulated time and concentration-dependent increases in p42/p44 MAPK and p38 MAPK phosphorylation in DDT(1)MF-2 cells. No increases in JNK phosphorylation were observed following adenosine A(1) receptor activation. N(6)-cyclopentyladenosine-mediated increases in p42/p44 MAPK and p38 MAPK phosphorylation were blocked by the selective adenosine A(1) receptor antagonist 1,3-dipropylcyclopentylxanthine and following pretreatment of cells with pertussis toxin. Furthermore, adenosine A(1) receptor-mediated increases in p42/p44 MAPK were sensitive to the MAPK kinase 1 inhibitor PD 98059 (2'-amino-3'-methoxyflavone), whereas p38 MAPK responses were blocked by the p38 MAPK inhibitor SB 203580 (4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole). The broad range protein tyrosine kinase inhibitors genistein and tyrphostin A47 (alpha-cyano-(3,4-dihydroxy)thiocinnamide) did not block adenosine A(1) receptor stimulation of p42/p44 MAPK. For comparison, insulin-mediated increases in p42/p44 MAPK were blocked by genistein and tyrphostin A47. The Src tyrosine kinase inhibitor PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine) and the epidermal growth factor receptor tyrosine kinase inhibitor AG1478 (4-(3-chloroanilino)-6,7-dimethoxyquinazoline) also had no effect on adenosine A(1) receptor stimulation of p42/p44 MAPK. Furthermore, the protein kinase C inhibitors Ro 31-8220 (3-[1-[3-(2-isothioureido) propyl]indol-3-yl]-4-(1-methylindol-3-yl)-3-pyrrolin-2,5-dione), chelerythrine and GF 109203X (2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)-maleimide) were without effect on adenosine A(1) receptor-induced p42/p44 MAPK phosphorylation. In contrast, wortmannin and LY 294002 (2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one), inhibitors of phosphatidylinositol 3-kinase, attenuated adenosine A(1) receptor stimulation of p42/p44 MAPK phosphorylation. In conclusion, the adenosine A(1) receptor stimulates p42/p44 MAPK through a pathway which appears to be independent of tyrosine kinase activation but involves phosphatidylinositol 3-kinase. Finally, adenosine A(1) receptor stimulation in DDT(1)MF-2 cells also activated p38 MAPK but not JNK via a pertussis toxin-sensitive pathway." @default.
• W2007298458 created "2016-06-24" @default.
• W2007298458 creator A5004128080 @default.
• W2007298458 creator A5034862572 @default.
• W2007298458 date "2001-02-01" @default.
• W2007298458 modified "2023-10-14" @default.
• W2007298458 title "Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A1 receptor in DDT1MF-2 cells" @default.
• W2007298458 cites W1498760971 @default.
• W2007298458 cites W1641731911 @default.
• W2007298458 cites W1775749144 @default.
• W2007298458 cites W1870773788 @default.
• W2007298458 cites W1909400967 @default.
• W2007298458 cites W1967432915 @default.
• W2007298458 cites W1971915141 @default.
• W2007298458 cites W1975889812 @default.
• W2007298458 cites W1975915718 @default.
• W2007298458 cites W1978231615 @default.
• W2007298458 cites W1980166477 @default.
• W2007298458 cites W1983023635 @default.
• W2007298458 cites W1985460150 @default.
• W2007298458 cites W1991076906 @default.
• W2007298458 cites W1992699915 @default.
• W2007298458 cites W2002453103 @default.
• W2007298458 cites W2007537092 @default.
• W2007298458 cites W2008396525 @default.
• W2007298458 cites W2009387204 @default.
• W2007298458 cites W2012441637 @default.
• W2007298458 cites W2014862487 @default.
• W2007298458 cites W2015648136 @default.
• W2007298458 cites W2034184306 @default.
• W2007298458 cites W2034825884 @default.
• W2007298458 cites W2055593439 @default.
• W2007298458 cites W2058376450 @default.
• W2007298458 cites W2059431546 @default.
• W2007298458 cites W2070944773 @default.
• W2007298458 cites W2073039482 @default.
• W2007298458 cites W2085547973 @default.
• W2007298458 cites W2088823687 @default.
• W2007298458 cites W2090895449 @default.
• W2007298458 cites W2091821996 @default.
• W2007298458 cites W2098719212 @default.
• W2007298458 cites W2106279971 @default.
• W2007298458 cites W2151477904 @default.
• W2007298458 cites W2166267283 @default.
• W2007298458 cites W2173637498 @default.
• W2007298458 cites W2252845142 @default.
• W2007298458 doi "https://doi.org/10.1016/s0014-2999(01)00761-0" @default.
• W2007298458 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11226388" @default.
• W2007298458 hasPublicationYear "2001" @default.
• W2007298458 type Work @default.
• W2007298458 sameAs 2007298458 @default.
• W2007298458 citedByCount "41" @default.
• W2007298458 countsByYear W20072984582012 @default.
• W2007298458 countsByYear W20072984582013 @default.
• W2007298458 countsByYear W20072984582014 @default.
• W2007298458 countsByYear W20072984582016 @default.
• W2007298458 countsByYear W20072984582019 @default.
• W2007298458 countsByYear W20072984582020 @default.
• W2007298458 countsByYear W20072984582021 @default.
• W2007298458 countsByYear W20072984582022 @default.
• W2007298458 crossrefType "journal-article" @default.
• W2007298458 hasAuthorship W2007298458A5004128080 @default.
• W2007298458 hasAuthorship W2007298458A5034862572 @default.
• W2007298458 hasConcept C126322002 @default.
• W2007298458 hasConcept C134018914 @default.
• W2007298458 hasConcept C170493617 @default.
• W2007298458 hasConcept C182683403 @default.
• W2007298458 hasConcept C184235292 @default.
• W2007298458 hasConcept C185592680 @default.
• W2007298458 hasConcept C2776991684 @default.
• W2007298458 hasConcept C2778938600 @default.
• W2007298458 hasConcept C55493867 @default.
• W2007298458 hasConcept C57074206 @default.
• W2007298458 hasConcept C67907053 @default.
• W2007298458 hasConcept C71924100 @default.
• W2007298458 hasConcept C86803240 @default.
• W2007298458 hasConcept C95444343 @default.
• W2007298458 hasConcept C97029542 @default.
• W2007298458 hasConceptScore W2007298458C126322002 @default.
• W2007298458 hasConceptScore W2007298458C134018914 @default.
• W2007298458 hasConceptScore W2007298458C170493617 @default.
• W2007298458 hasConceptScore W2007298458C182683403 @default.
• W2007298458 hasConceptScore W2007298458C184235292 @default.
• W2007298458 hasConceptScore W2007298458C185592680 @default.
• W2007298458 hasConceptScore W2007298458C2776991684 @default.
• W2007298458 hasConceptScore W2007298458C2778938600 @default.
• W2007298458 hasConceptScore W2007298458C55493867 @default.
• W2007298458 hasConceptScore W2007298458C57074206 @default.
• W2007298458 hasConceptScore W2007298458C67907053 @default.
• W2007298458 hasConceptScore W2007298458C71924100 @default.
• W2007298458 hasConceptScore W2007298458C86803240 @default.
• W2007298458 hasConceptScore W2007298458C95444343 @default.
• W2007298458 hasConceptScore W2007298458C97029542 @default.
• W2007298458 hasIssue "2-3" @default.
• W2007298458 hasLocation W20072984581 @default.
• W2007298458 hasLocation W20072984582 @default.
• W2007298458 hasOpenAccess W2007298458 @default.
• W2007298458 hasPrimaryLocation W20072984581 @default.

• next